These data are the first to our knowledge to demonstrate LPAR expression differences on tumor-infiltrating CD8+ T cells as a function of anti–PD-1 treatment resistance and could reveal important biology about the involvement of these receptors in trafficking, activation, and cytotoxicity. Here, CD8A is linked to neoplasm.